Ftse Mib
34.571,62
-0,30%
DAX
19.147,85
-0,54%
S&P 500
5.721,73
-0,12%
NASDAQ
18.224,58
-0,08%
Bitcoin
67.641,99
-1,60%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Embecta Corporation (EMBC) Embecta Corporation (EMBC) Notizie

Embecta Corporation

EMBC
14,485
0,235 (1,65%)
Ultimo aggiornamento: 18:59:52
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/9/202412:30GLOBEembecta Announces FDA Clearance of its Disposable Patch Pump..
22/8/202423:00GLOBEembecta to Participate in Investor Events
12/8/202423:08EDGAR2Form 8-K - Current report
09/8/202418:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202413:01EDGAR2Form 8-K - Current report
09/8/202412:30GLOBEEmbecta Corp. Reports Third Quarter Fiscal 2024 Financial..
09/8/202412:00GLOBEembecta Announces Quarterly Cash Dividend
09/8/202411:50IHMARKETNEWSUS Futures Climb Following Thursday’s Rally, Oil Prices..
29/7/202414:05PRNUSGenpact Supports embecta's Spin-Off into an Independent..
18/7/202423:00GLOBEembecta to Report Fiscal Third Quarter 2024 Financial..
24/6/202412:30GLOBEembecta-sponsored Abstracts Presented at American Diabetes..
14/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202419:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:02EDGAR2Form 8-K - Current report
09/5/202412:30GLOBEEmbecta Corp. Reports Second Quarter Fiscal 2024 Financial..
09/5/202412:00GLOBEembecta Announces Quarterly Cash Dividend
01/5/202423:00GLOBEembecta to Participate in Investor Events
23/4/202423:00GLOBEembecta to Report Fiscal Second Quarter 2024 Financial..
06/3/202412:00GLOBEembecta-sponsored Educational Symposium and Abstracts at..
14/2/202416:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:30EDGAR2Form 8-K - Current report
09/2/202418:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202412:52EDGAR2Form 8-K - Current report
09/2/202412:30GLOBEEmbecta Corp. Reports First Quarter Fiscal 2024 Financial..
09/2/202412:00GLOBEembecta Announces Quarterly Cash Dividend
07/2/202423:00GLOBEembecta to Participate in the 11th Annual BTIG MedTech..
24/1/202423:00GLOBEembecta to Report Fiscal First Quarter 2024 Financial..
09/1/202412:00GLOBEembecta Announces FDA 510(k) Submission for Insulin Patch..
19/12/202322:18EDGAR2Form ARS - Annual Report to Security Holders
19/12/202322:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
14/12/202323:00GLOBEembecta to Participate at the 42nd Annual J.P. Morgan..
01/12/202312:00GLOBENo embecta-made syringes impacted by FDA safety..
29/11/202323:00GLOBEembecta to Participate in Investor Conferences
29/11/202322:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/11/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202302:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202312:11EDGAR2Form 8-K - Current report
21/11/202311:30GLOBEEmbecta Corp. Reports Fiscal 2023 Fourth Quarter and Full..
21/11/202311:00GLOBEembecta Announces Quarterly Cash Dividend
Apertura: 14,19 Min: 14,02 Max: 14,695
Chiusura: 14,25

La tua Cronologia

NASDAQ
EMBC
Embecta
NASDAQ
HGEN
Humanigen
AMEX
ADGE
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network